UK pharmaceutical sector ‘risks losing investment to other countries’
AI-Generated Summary
Research indicates the UK pharmaceutical sector's investment has underperformed global trends since 2018, with a significant decline in foreign funding and R&D spending. Industry leaders warn that the UK risks losing out on vital investment to other countries and urge collaboration between government and industry to remove existing barriers.
In a nutshell
This report underscores a critical challenge for the UK, potentially impacting its economic growth and capacity for healthcare innovation. It highlights the urgent need for strategic policy adjustments to ensure the UK remains competitive in the global life sciences sector.
Source: LBC
